HKU and CUHK medical faculties to showcase biotech strengths at BIO 2025
發佈日期: 2025-06-11 22:35
TVB News
This month, Hong Kong's two leading medical faculties, the University of Hong Kong and the Chinese University of Hong Kong, are making their debut at BIO 2025 in Boston, the world's largest biotechnology conference.
Their participation will showcase on the global stage Hong Kong's growing strength in biotechnology research.
For the first time, representatives of the medical faculties of HKU and CUHK will join the Hong Kong delegation to BIO 2025.
ALBERT WONG, Chief Executive Officer, HK Science and Technology Parks Corporation: We want to bring our technologies to the world to understand how we can play bigger. Systems in the U.S. and other parts of the world are different and we need to adapt to it and we need to learn how to bring our technologies and make them be successful.
The CEO of the Hong Kong Science and Technology Parks Corporation attributed the delegations' preparation and anticipated success at the conference to the existence of the two university medical faculties in training local talent and conducting biomedical research.
The dean of the HKU Li Ka Shing Faculty of Medicine emphasised that the local ecosystem promotes technology development and transfer.
He pointed to the Hong Kong government's establishment of the InnoHK Centres, five of which are associated with HKU, as encouraging academics to transfer breakthroughs from labs into impactful medical products.
The two medical faculties have also focused their efforts on talent development, both locally and abroad, encouraging students to pursue careers in medical research.
The dean of the CUHK Faculty of Medicine stressed that the city's position within the Greater Bay Area allows it to take on global challenges and conduct multi-centre, high-level clinical trials which will be translated to impactful applications, a unique attraction to international talent.
The delegation aims to showcase such strengths at the BIO international convention in the hope of further expanding the local biotech industry.
